Edgewell Personal Care Company remains a "Buy" after a successful business transformation and significant debt reduction following the Feminine Care segment divestiture. EPC's valuation is compelling, trading at attractive multiples both absolutely and relative to peers, with only one comparable cheaper on key metrics. Recent results show modest revenue growth, mixed profitability, and temporary supply constraints in Wet Shave, but Sun & Skin Care delivered strong organic sales gains.
AGX's larger EPC contracts and rising project values could accelerate its path toward $2B in annual revenue without doubling project count.
Edgewell Personal Care NYSE: EPC reported a return to organic sales growth in its fiscal third quarter of 2026, supported by improved North American performance in grooming, sun and skin care, and branded wet shave. The company said adjusted earnings per share and adjusted EBITDA exceeded its internal expectations, while it maintained the midpoint of its full-year outlook.
Edgewell Personal Care (EPC) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.92 per share a year ago.
Edgewell Personal (EPC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CQP advances its Sabine Pass Expansion Project by signing an EPC contract with Bechtel, targeting Phase 1 LNG production capacity of more than 6 MPTA.
Edgewell Personal Care NYSE: EPC reported fiscal second-quarter results that exceeded management's expectations, with executives pointing to improving U.S. consumption trends, international market share gains and stronger execution across core categories following the divestiture of its Feminine Care business.
Edgewell Personal Care Company (EPC) Q2 2026 Earnings Call Transcript
Edgewell Personal Care (EPC) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.87 per share a year ago.
Edgewell Personal (EPC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Engineering, procurement, and construction (EPC) firms are expected to play a significant role in the nuclear renaissance. Accordingly, this would present a compelling opportunity for investors.
Edgewell Personal Care is undergoing a strategic transformation, selling its feminine-care segment for $340M to reduce debt and refocus on core brands. EPC plans to significantly increase advertising for its razors and sunscreen in 2026, aiming to defend market share and reignite revenue growth. Despite high leverage (net debt/EBITDA ~4.6 post-sale), EPC trades at a steep discount to peers, with a projected one-year target price of $28.63—44% above current levels.